RADIOGRAPHIC PROGRESSION-FREE SURVIVAL (RPFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN CHEMOTHERAPY-NAIVE METASTATIC CASTRATIONRESISTANT PROSTATE CANCER (MCRPC): A CORRELATION META-ANALYSIS

被引：0
|
作者：
Leung, L. [1 ]
Patel, M. [2 ]
Teitsson, S. [3 ]
Hofer, K. [1 ]
Qian, A. [1 ]
Kurt, M. [4 ]
机构：
[1] Evidinno Outcomes Res Inc, Vancouver, BC, Canada
[2] Bristol Myers Squibb, Lawrenceville, NJ USA
[3] Bristol Myers Squibb, Uxbridge, Middx, England
[4] Bristol Myers Squibb, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO55
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [1] RADIOGRAPHIC PROGRESSION FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL AMONG MEN WITH METASTATIC CASTRATIONRESISTANT PROSTATE CANCER
    Maheshwari, V. K.
    Biswas, A.
    Chakravarty, A.
    Vanderpuye-Orgle, J.
    Pandey, P.
    Kondaparthi, P.
    VALUE IN HEALTH, 2023, 26 (12) : S24 - S24
  • [2] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [3] Radiographic progression-free survival as a surrogate endpoint of overall survival in men with metastatic castrate-resistant prostate cancer.
    Halabi, Susan
    Roy, Akash
    Yang, Qian
    Xie, Wanling
    Kelly, William Kevin
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
    Sjoquist, Katrin M.
    Lord, Sarah J.
    Friedlander, Michael L.
    Simes, Robert John
    Marschner, Ian C.
    Lee, Chee Khoon
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10 : 1 - 16
  • [5] Correlation between radiographic progression-free survival (rPFS) and overall survival (OS): Results from PREVAIL.
    Morris, Michael J.
    Beer, Tomasz M.
    Loriot, Yohann
    Higano, Celestia S.
    Armstrong, Andrew J.
    Sternberg, Cora N.
    De Bono, Johann S.
    Tombal, Bertrand F.
    Parli, Teresa
    Bhattacharya, Suman
    Krivoshik, Andrew P.
    Phung, De
    Rathkopf, Dana E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [6] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [7] Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2015, 17 (05) : 764 - 765
  • [8] EVALUATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER: SYSTEMATIC REVIEW AND TRIAL LEVEL META-ANALYSIS
    Adunlin, G.
    Dranitsaris, G.
    VALUE IN HEALTH, 2016, 19 (03) : A170 - A170
  • [9] Analysis of the temporal relationship between patient-reported outcomes (PROs) and overall survival (OS) and radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
    Traina, Shana
    Li, Tracy
    Johnson, Kristen
    Ho, Kai Fai
    Molina, Arturo
    Cella, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [10] PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN PREVIOUSLY UNTREATED ADVANCED MELANOMA: A CORRELATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)
    Leung, L.
    Chou, E.
    Kurt, M.
    Moshyk, A.
    Hamilton, M.
    Pourrahmat, M. M.
    Kanters, S.
    VALUE IN HEALTH, 2022, 25 (01) : S22 - S22
12345